COVID-19 vaccines reduce infection, disease severity, and death by SARS-CoV-2 by reducing viral load. This study aimed to evaluate the change of cycle threshold (Ct) value in COVID-19 patients and investigate factors related to the Ct value change on the 3rd (D3), 7th (D7), 10th (D10), and 14th (D14) day after hospital admission in Dak Lak in 2021. Nasopharyngeal swabs and serum samples were obtained from 251 COVID-19 patients. Samples were collected on D3, D7, D10, and D14 after hospital admission and tested for SARS-CoV-2 by real-time RT-PCR tests. Ct values were categorized as high viral load, moderate viral, and low viral load. Electrochemiluminescence immunoassay was used to estimate the anti-SARS-CoV-2 antibodies. The results demonstrated that vaccinated individuals against COVID-19 have a faster rate of hospital discharge than the unvaccinated group, most clearly on D10. The Ct change on D10 of vaccinated individuals was statistically significantly higher (1.35 times) than of unvaccinated individuals (P < 0.01). The mean Ct values of unvaccinated individuals on D3, D7, D10, and D14 were lower than that of vaccinated individuals. However, there was a statistically significant increase in Ct of vaccinated individuals compared to unvaccinated individuals only on D10 and D14 (P < 0.03). The percentage of Ct value ≥ 30 and negative of vaccinated persons on D7 (60.9%) was similar to that of unvaccinated persons on D10 (59.4%) (P > 0.05). Vaccinated individuals at hospital admission with Ct ≤ 20 on D1 had a statistically significant decline in viral load on D10 and D14, 1.55 and 1.30 times higher compared to unvaccinated individuals (P < 0.05). The percentage of Ct ≥ 30 was significantly higher in males than females, especially on D7 and D14 with PR = 1.26 and 1.11 (P < 0.05). In conclusion, individuals vaccinated against COVID-19 had reduced transmission by a significant decline in viral load and recovered faster than unvaccinated individuals.
Citation: Chien Chinh Vien, Tuan Van Le, Van Tuyet Thi Nguyen, Thang Nghia Hoang, Phila Nay. Viral load dynamics of SARS-CoV-2 in the moderately symptomatic COVID-19 patients in Dak Lak, Viet Nam, 2021[J]. AIMS Medical Science, 2025, 12(1): 1-12. doi: 10.3934/medsci.2025001
COVID-19 vaccines reduce infection, disease severity, and death by SARS-CoV-2 by reducing viral load. This study aimed to evaluate the change of cycle threshold (Ct) value in COVID-19 patients and investigate factors related to the Ct value change on the 3rd (D3), 7th (D7), 10th (D10), and 14th (D14) day after hospital admission in Dak Lak in 2021. Nasopharyngeal swabs and serum samples were obtained from 251 COVID-19 patients. Samples were collected on D3, D7, D10, and D14 after hospital admission and tested for SARS-CoV-2 by real-time RT-PCR tests. Ct values were categorized as high viral load, moderate viral, and low viral load. Electrochemiluminescence immunoassay was used to estimate the anti-SARS-CoV-2 antibodies. The results demonstrated that vaccinated individuals against COVID-19 have a faster rate of hospital discharge than the unvaccinated group, most clearly on D10. The Ct change on D10 of vaccinated individuals was statistically significantly higher (1.35 times) than of unvaccinated individuals (P < 0.01). The mean Ct values of unvaccinated individuals on D3, D7, D10, and D14 were lower than that of vaccinated individuals. However, there was a statistically significant increase in Ct of vaccinated individuals compared to unvaccinated individuals only on D10 and D14 (P < 0.03). The percentage of Ct value ≥ 30 and negative of vaccinated persons on D7 (60.9%) was similar to that of unvaccinated persons on D10 (59.4%) (P > 0.05). Vaccinated individuals at hospital admission with Ct ≤ 20 on D1 had a statistically significant decline in viral load on D10 and D14, 1.55 and 1.30 times higher compared to unvaccinated individuals (P < 0.05). The percentage of Ct ≥ 30 was significantly higher in males than females, especially on D7 and D14 with PR = 1.26 and 1.11 (P < 0.05). In conclusion, individuals vaccinated against COVID-19 had reduced transmission by a significant decline in viral load and recovered faster than unvaccinated individuals.
| [1] |
Zhu N, Zhang D, Wang W, et al. (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382: 727-733. https://doi.org/10.1056/NEJMoa2001017
|
| [2] |
Zhou P, Yang XL, Wang XG, et al. (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579: 270-273. https://doi.org/10.1038/s41586-020-2012-7
|
| [3] | WHO (2022) WHO Coronavirus (COVID-19) Dashboard 2022. Updated 25 August 2022. Accessed December 20, 2022. Available from: https://covid19.who.int/ |
| [4] |
Harris RJ, Hall JA, Zaidi A, et al. (2021) Effect of vaccination on household transmission of SARS-CoV-2 in England. N Engl J Med 385: 759-760. https://doi.org/10.1056/NEJMc2107717
|
| [5] |
Levine-Tiefenbrun M, Yelin I, Katz R, et al. (2021) Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med 27: 790-792. https://doi.org/10.1038/s41591-021-01316-7
|
| [6] | Lyngse FP, Mølbak K, Træholt Franck K, et al. (2021) Association between SARS-CoV-2 transmissibility, viral load, and age in households. medRxiv . https://doi.org/10.1101/2021.02.28.21252608 |
| [7] |
Singanayagam A, Patel M, Charlett A, et al. (2020) Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill 25: 2001483. https://doi.org/10.2807/1560-7917.ES.2020.25.32.2001483
|
| [8] | Vietnam Ministry of Health. Decision No. 3416/QĐ-BYT dated July 14 2021 on promulgating the criteria for the classification of the risk of people infected with SARS-CoV-2. Available from: https://thuvienphapluat.vn/van-ban/The-thao-Y-te/Quyet-dinh-3416-QD-BYT-2021-Huong-dan-chan-doan-COVID-19-do-chung-vi-rut-Corona-moi-481044.aspx. (In Vietnamese) |
| [9] | National Steering Committee for COVID-19 Prevention and control (NSC). Results of two years of implementation for COVID-19 preventation. In: COVID-19, editor. Hanoi 2022. Available from: https://moh.gov.vn/documents/174521/1197117/4.+BC+k%E1%BA%BFt+qu%E1%BA%A3+02+n%C4%83m+tri%E1%BB%83n+khai+c%C3%B4ng+t%C3%A1c+ph%C3%B2ng%2C+ch%E1%BB%91ng+d%E1%BB%8Bch+COVID-19.pdf/e3254b2a-c902-4696-b0c7-cc4427b8f992. (In Vietnamese) |
| [10] |
Zhang S, Xu K, Li C, et al. (2022) Long-term kinetics of SARS-CoV-2 antibodies and impact of inactivated vaccine on SARS-CoV-2 antibodies based on a COVID-19 patients cohort. Front Immunol 13: 829665. https://doi.org/10.3389/fimmu.2022.829665
|
| [11] |
Jung J, Kim JY, Park H, et al. (2022) Transmission and infectious SARS-CoV-2 shedding kinetics in vaccinated and unvaccinated individuals. JAMA Netw Open 5: e2213606. https://doi.org/10.1001/jamanetworkopen.2022.13606
|
| [12] |
Pritchard E, Matthews PC, Stoesser N, et al. (2021) Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nat Med 27: 1370-1378. https://doi.org/10.1038/s41591-021-01410-w
|
| [13] |
Wu J, Wei Y, Shen F, et al. (2022) Vaccination is associated with shorter time to target cycle threshold value in patients with SARS-CoV-2 Omicron variant. Front Cell Infect Microbiol 12: 943407. https://doi.org/10.3389/fcimb.2022.943407
|
| [14] |
Goldstein E, Lipsitch M, Cevik M (2021) On the effect of age on the transmission of SARS-CoV-2 in households, schools, and the community. J Infect Dis 223: 362-369. https://doi.org/10.1093/infdis/jiaa691
|
| [15] |
Mathur R, Rentsch CT, Morton CE, et al. (2021) Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet 397: 1711-1724. https://doi.org/10.1016/S0140-6736(21)00634-6
|
| [16] |
Acharya CB, Schrom J, Mitchell AM, et al. (2022) Viral load among vaccinated and unvaccinated, asymptomatic and symptomatic persons infected with the SARS-CoV-2 Delta variant. Open Forum Infect Dis 9: ofac135. https://doi.org/10.1093/ofid/ofac135
|
| [17] |
Aranha C, Patel V, Bhor V, et al. (2021) Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: an approach to reduce the isolation period for COVID-19 patients. J Med Virol 93: 6794-6797. https://doi.org/10.1002/jmv.27206
|
| [18] |
Eyre DW, Taylor D, Purver M, et al. (2022) Effect of Covid-19 vaccination on transmission of Alpha and Delta variants. N Engl J Med 386: 744-756. https://doi.org/10.1056/NEJMoa2116597
|
| [19] |
Acosta AM, Garg S, Pham H, et al. (2021) Racial and ethnic disparities in rates of COVID-19–associated hospitalization, intensive care unit admission, and in-hospital death in the United States from March 2020 to February 2021. JAMA Netw Open 4: e2130479. https://doi.org/10.1001/jamanetworkopen.2021.30479
|
| [20] |
Escobar GJ, Adams AS, Liu VX, et al. (2021) Racial disparities in COVID-19 testing and outcomes: retrospective cohort study in an integrated health system. Ann Intern Med 174: 786-793. https://doi.org/10.7326/M20-6979
|
| [21] |
Azar KMJ, Shen Z, Romanelli RJ, et al. (2020) Disparities in outcomes among COVID-19 patients in a large health care system in California. Health Aff 39: 1253-1262. https://doi.org/10.1377/hlthaff.2020.00598
|
| [22] |
Nafilyan V, Islam N, Ayoubkhani D, et al. (2021) Ethnicity, household composition and COVID-19 mortality: a national linked data study. J R Soc Med 114: 182-211. https://doi.org/10.1177/0141076821999973
|
| [23] | Ghamarchehreh ME, Ashoori H, Vahidian F, et al. (2022) Association of SARS-COV-2 cycle threshold values with clinical and epidemiological features of children and adolescents in Iran. Int J Pediatr 10: 16174-16181. https://10.22038/ijp.2022.61977.4753 |
| [24] |
Li L, Tan C, Zeng J, et al. (2021) Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients. J Transl Med 19: 30. https://doi.org/10.1186/s12967-020-02693-2
|
| [25] |
Saglik I, Ener B, Akalin H, et al. (2022) Association of SARS-CoV-2 cycle threshold (Ct) values with clinical course and serum biomarkers in COVID-19 patients. J Infect Dev Ctries 16: 445-452. https://doi.org/10.3855/jidc.15818
|